ELI-004

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameELI-004
Drug Alias NameTLR-9 agonist (Elicio Therapeutics)ELI-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll like receptor 9 agonists
TargetsToll like receptor 9
Therapy Area/IndicationsVaccinationNeoplasmsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesElicio Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesElicio Therapeutics Inc
Inactive CompaniesElicio Therapeutics
Active IndicationsVaccinationNeoplasmsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A